Equitas Holdings Limited IPO Message Board (Page 9)

Equitas now at 135 labels, i remember After listing a member had said that blind short selling of equitas on listing days , and on Monday short covering can take it to 145 or 149 ,

If Equitas breaks 135 it will be a disaster ... :(

Equitas is showing support @135.
B/S ratio is 1:5, still stock is maintaining the level of Rs.135.

Septa and all,

I am holding Alkem and equitas of ipo price, I have money short fall,

1. Can I sell Alkem and apply

2. Can i sell equitas and apply

After these ipo are over , again enter in sold companies is reasonable valuations are there.

Please reply.

If we compare equitas and alkem for holding point of view , Equitas is superior than Alkem.
Alkem is a stock , which have a huge upside potential. There are multiple reasons i.e. 75% + revenue of Alkem is from India which no other major pharma company have in the present uncertain USFDA and Regulatory flag environment. However Alkem had also received such warnings but it will be least impacted in its Top line and bottom line results.
U will remember me, once their results will be declared.

Equitas had a great potential as SFB licence holder . in past, no one can imagine the level of kotak mahindra bank and Yes bank, as they are at the moment. Equitas and Ujjivan both have the similar long term potential.
I have taken fresh position at 135 in equitas and 1250 in Alkem in addition to IPO allotment.
I m not a expert. Also new in this forum. Septa sir and others can correct me, if i am wrong in my assumptions.

How I know reision rejection of equitas holding applications

Do all you people pay tax as short term capital gain. how to keep record that how much I earn in a financial year. I have demat with sharekhan

You can give a call to ShareKhan for providing a statement on capital gain.

I will hold this share to the 200 level because allotment chances in coming ipos is less

So now with this improved credit rating ... How much will the cost of funds reduce for Equitas ?

Cost of Funds is derived by dividing the short term borrowing by interest payout. With improve credit rating it can save on interest part and it will be 2 to 3 %.

Effective cost of funds can''t come down by 2-3% just because of 1-notch upgrade in rating which was already good. 2-3% cost saving is huge for lending institutions whose NIM is usually around 3%.

A 25 bps saving in cost could be imagined.

Eagleye equita is good bet for 12 month view at current price pls suggest

I will NOT sell Equitas ...

I shall hold for at least a target price of RS.200/- ... And even at that level I shall review whether I want to sell or continue to hold

Sultan,

While, Thyrocare is a good punt to buy in IPO but then sell soon after listing.

Whereas, Equitas & Ujjivan are both super good quality stocks to keep in long term portfolio

That''''s the advise I have been given by market experts ...

BSE:

Upgrading of Credit Rating by CRISIL             23 Apr 2016 18:30
Equitas Holdings Ltd has informed BSE that CRISIL Limited vide its letter dated April 22, 2016 has upgraded the rating for the long term instruments of the Company''s subsidiaries viz., Equitas Micro Finance Limited and Equitas Housing Finance Limited to ''CRISIL A/Stable'' from ''CRISIL A-/Stable''.

In respect of the Company''s subsidiary, Equitas Finance Limited, CRISIL has reaffirmed the rating of ''CRISIL A1" (pronounced as CRISIL A one rating) for the short term debt instruments.




Now that''s a positive news for stock ;)

yes now they can borrow at a cheaper rate which will surely have impact on it bottom line and have positive effect on share price

http://www.bseindia.com/corporates/anndet_new.aspx?newsid=82d9bcd1-56f3-4ff0-9586-11cbcf619057

Equitas Holdings

NAV (post IPO) = 58.56 & NAV FY17 = 65.54

@138 (CMP)

P/Bv (post IPO) = 2.36 & P/Bv FY17 = 2.11

Looks very attractive valuation at current prices ... (relative to peer group)

Inviting comments by Experts ... please guide me

Heard on the Street :

Equitas price target >>>
155+ by 10th May 2016
200+ by November 2016

I will wait till 10th May to sell my alloted shares. I wish it will be correct as always.

agree :)
i think it will go up from 3rd may
logic :jyada rii new ipo main block honge.

Equitas hold kare ya nikal jaye.plz reply eagleeye. I have 5 lot.

What is the basis of allotment in NII catrgory in case of oversubscription? Plz reply

I have 2 demat accounts & i sold it on listing day itself @141.5(aprox 8000 rs.).

Happppppyyyyyy

Respected septaji what is our opinioun about alkem lab.i want to buy at current price..

i actual sold my position few days back i am not the bullish on Pharma stock given USDFA has increased the number of officer big time plans to raise the number of inspectors to 5,000 in three to five years, from about 1,500.... this will see big increase in audit and finding all this will certainly effect top and bottom line.

At least in case of ALkem revenue is more local so it is actual good contra bet in Pharma but still it will have effects of US FDA.....


I will entry if comes close to issue price or there abt

Also HB eagle eye on ur 25th

Hello All,

I am new to this board... :-)
Need your suggestion .... I have still 135 shares of Equitas.. should hold or sell ??

I would suggest you hold until Diwali''16 or a price target of 200 .. whichever comes earlier

equitas not go up

Vodafone IPO likely to hit market

Media reports- Vodafone IPO likely to hit market  As per the media reports, the listing of Vodafones Indian unit is on its way.

The company is expected to raise between $2-$2.5 billion.

9 to 12 months in the future... Definitely not in calendar 2016

why precison camshaft going down more ? hold or sell

lagta h Eagleye mehul bhai ke peche pad gaye h.

Mehulbhai ka pehle ka post read karo..ye bahotbada feku he.

mehul bhai lota ki tarah. ghumta rehta. he bin peda ka lota..

I am taking about pre cem "stock not about EHL''S target

you said that people book losses in precam
Quick heal and HCG also loss making IPOs why people dont book losses in these stocks.
They only book losses in precam.